Krystal Biotech (KRYS) PT Lowered to $107 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis lowered the price target on Krystal Biotech (NASDAQ: KRYS) to $107.00 (from $124.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
